Previous studies (31–34) have shown that patients who had BCs with HER2 positivity, TN subtypes, high Ki67 expression, higher histological grade, lower initial cN, and good tumor response to NAC were more likely to achieve apCR. This evidence concerns the gene ERBB2 and neoplasm.